We are live on
!
Find out more
TCM
Tamarack Capital Management Portfolio holdings
AUM
$840M
1-Year Est. Return
19.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.87%
1 Year Est. Return
+19.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$179M
AUM Growth
–
Cap. Flow
+$179M
Cap. Flow
% of AUM
100.38%
Top 10 Holdings %
Top 10 Hldgs %
61.22%
Holding
24
New
24
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alkermes
ALKS
|
+$16M |
| 2 |
Pacira BioSciences
PCRX
|
+$15.9M |
| 3 |
Integer Holdings
ITGR
|
+$15.5M |
| 4 |
MDAS
MEDASSETS INC COM STK (DE)
MDAS
|
+$10.4M |
| 5 |
AGN
Allergan Inc
AGN
|
+$9.86M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.85% |
| 2 | Technology | 3.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Integer Holdings
ITGR
$3.35B
| $16.4M | 9.18% |
+548,500
| New | +$15.5M |
|
|
2
Pacira BioSciences
PCRX
$1.02B
| $15.9M | 8.92% |
+548,900
| New | +$15.9M |
|
|
3
Alkermes
ALKS
$8.82B
| $15.8M | 8.84% |
+550,000
| New | +$16M |
|
|
MDAS
4
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $10.3M | 5.77% |
+581,094
| New | +$10.4M |
|
|
VPHM
5
DELISTED
VIROPHARMA INC
VPHM
| $9.31M | 5.22% |
+325,000
| New | +$8.57M |
|
6
Haemonetics
HAE
$3.58B
| $9.3M | 5.21% |
+225,000
| New | +$9.11M |
|
7
AtriCure
ATRC
$1.77B
| $8.29M | 4.64% |
+872,447
| New | +$7.6M |
|
|
SRGA
8
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $8.13M | 4.55% |
+72,062
| New | +$8.81M |
|
|
AGN
9
DELISTED
Allergan Inc
AGN
| $8M | 4.48% |
+95,000
| New | +$9.86M |
|
10
DexCom
DXCM
$27.6B
| $7.86M | 4.4% |
+1,400,000
| New | +$6.71M |
|
11
CALL
Teva Pharmaceuticals
TEVA
$35.9B
| $7.84M | 4.39% |
+200,000
| New | +$7.79M |
|
|
VAR
12
DELISTED
Varian Medical Systems, Inc.
VAR
| $7.76M | 4.35% |
+131,144
| New | +$7.85M |
|
|
SPNC
13
DELISTED
Spectranetics Corp
SPNC
| $7.46M | 4.18% |
+399,627
| New | +$7.56M |
|
|
VCRA
14
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.94M | 3.89% |
+472,105
| New | +$8.07M |
|
15
Perrigo
PRGO
$1.4B
| $6.66M | 3.73% |
+55,000
| New | +$6.52M |
|
|
COV
16
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $6.6M | 3.7% |
+118,440
| New | +$6.85M |
|
17
Labcorp
LH
$24.3B
| $6.51M | 3.64% |
+75,660
| New | +$6.28M |
|
|
VOLC
18
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $5.79M | 3.24% |
+319,443
| New | +$6.11M |
|
|
SLTM
19
DELISTED
SOLTA MED INC (DE)
SLTM
| $4.11M | 2.3% |
+1,804,391
| New | +$3.81M |
|
20
Bruker
BRKR
$9.2B
| $3.23M | 1.81% |
+200,000
| New | +$3.46M |
|
21
Standard BioTools
LAB
$326M
| $2.52M | 1.41% |
+144,402
| New | +$2.53M |
|
|
NTUS
22
DELISTED
Natus Medical Inc
NTUS
| $2.06M | 1.16% |
+151,144
| New | +$2.06M |
|
|
GTIV
23
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $1.34M | 0.75% |
+134,547
| New | +$1.4M |
|
|
AUXL
24
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $416K | 0.23% |
+25,000
| New | +$399K |
|
Similar funds
RI
CWA
GHF
F
TRV
BMCMI
GACM
AH
Tamarack Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Tamarack Capital Management, which disclosed 24 positions worth $179M. Its ten largest holdings account for 61% of the portfolio.
Its largest position is Alkermes: 550,000 shares worth $15.8M.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, followed by Technology.
- Tamarack Capital Management's largest Q2 2013 buy was Alkermes: 550,000 shares worth $15.8M.
- Tamarack Capital Management's ten largest holdings make up 61% of its $179M portfolio in Q2 2013.
- Tamarack Capital Management disclosed 24 positions in Q2 2013, its first 13F filing on record.
Based on Tamarack Capital Management's 13F filing for Q2 2013, filed 9 Aug 2013.